Ruthenium(ii) polypyridyl complexes with visible light-enhanced anticancer activity and multimodal cell imaging

被引:2
|
作者
Kang, Yan [1 ,2 ,3 ,4 ,5 ,6 ]
Zhao, Yao [1 ,2 ,3 ,4 ,7 ,8 ]
Wei, Yuanyuan [1 ,2 ,3 ,4 ,5 ]
Zhang, Yang [1 ,2 ,3 ,4 ,7 ]
Wang, Zhaoying [1 ,2 ,3 ,4 ,7 ]
Luo, Qun [1 ,2 ,3 ,4 ,7 ]
Du, Jun [5 ]
Wang, Fuyi [1 ,2 ,3 ,4 ,7 ]
机构
[1] Chinese Acad Sci, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China
[2] Chinese Acad Sci, CAS Key Lab Analyt Chem Living Biosyst, Beijing 100190, Peoples R China
[3] Chinese Acad Sci, Natl Ctr Mass Spectrometry Beijing, Beijing 100190, Peoples R China
[4] Chinese Acad Sci, Inst Chem, Beijing 100190, Peoples R China
[5] Anhui Normal Univ, Coll Chem & Mat Sci, Key Lab Funct Mol Solids, Anhui Lab Mol Based Mat,Minist Educ, Wuhu 241000, Peoples R China
[6] Natl Univ Def Technol, Coll Adv Interdisciplinary Studies, Changsha 410073, Peoples R China
[7] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[8] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
EPIDERMAL-GROWTH-FACTOR; METAL-COMPLEXES; IN-VITRO; DNA; LIGANDS; SINGLE; APOPTOSIS; RECEPTOR; THERAPY; DRUG;
D O I
10.1039/d3dt01661g
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Ruthenium(ii) polypyridyl complexes have drawn growing attention due to their photophysical properties and anticancer activity. Herein we report four ruthenium(ii) polypyridyl complexes [(N<^>N)(2)Ru-II(L)](2+) (1-4, L = 4-anilinoquinazoline derivatives, N<^>N = bidentate ligands with bis-nitrogen donors) as multi-functional anticancer agents. The epidermal growth factor receptor (EGFR) is overexpressed in a broad range of cancer cells and related to many kinds of malignance. EGFR inhibitors, such as gefitinib and erlotinib, have been approved as clinical anticancer drugs. The EGFR-inhibiting 4-anilinoquinazoline ligands greatly enhanced the in vitro anticancer activity of these ruthenium(ii) polypyridyl complexes against a series of human cancer cell lines compared to [Ru(bpy)(2)(phen)], but interestingly, these complexes were actually not potent EGFR inhibitors. Further mechanism studies revealed that upon irradiation with visible light, complexes 3 and 4 generated a high level of singlet oxygen (O-1(2)), and their in vitro anticancer activities against human non-small-cell lung (A549), cervical (HeLa) and squamous (A431) cancer cells were significantly improved. Specifically, complex 3 displayed potent phototoxicity upon irradiation with blue light, of which the photo-toxicity indexes (PIs) against HeLa and A431 cells were 11 and 8.3, respectively. These complexes exhibited strong fluorescence emission at ca. 600 nm upon excitation at about 450 nm. A subcellular distribution study by fluorescence microscopy imaging and secondary ion mass spectrometry imaging (ToF-SIMS) demonstrated that complex 3 mainly localized at the cytoplasm and complex 4 mainly localized in the nuclei of cells. Competitive binding with ctDNA showed that complex 4 was more favorable to bind to the DNA minor groove than complex 3. These differences support that complex 3 possibly exerts its anticancer activities majorly by photo-induced O-1(2) generation and complex 4 by binding to DNA.
引用
收藏
页码:12478 / 12489
页数:12
相关论文
共 50 条
  • [31] Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes
    Dou, Ye-Hong
    Xu, Shou-De
    Chen, Yi
    Wu, Xiang-Hua
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2017, 192 (11) : 1219 - 1223
  • [32] Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes
    Leonor Côrte-Real
    Filipa Mendes
    Joana Coimbra
    Tânia S. Morais
    Ana Isabel Tomaz
    Andreia Valente
    M. Helena Garcia
    Isabel Santos
    Manuel Bicho
    Fernanda Marques
    JBIC Journal of Biological Inorganic Chemistry, 2014, 19 : 853 - 867
  • [33] Trinuclear ruthenium(II) polypyridyl complexes: Evaluation as photosensitizers for enhanced cervical cancer treatment
    Welsh, Athi
    Matshitse, Refilwe
    Khan, Saif F.
    Nyokong, Tebello
    Prince, Sharon
    Smith, Gregory S.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2024, 256
  • [34] Effect of ancillary ligands on the topoisomerases II and transcription inhibition activity of polypyridyl ruthenium(II) complexes
    Chen, Xing
    Gao, Feng
    Zhou, Zhu-Xin
    Yang, Wei-Yan
    Guo, Li-Tian
    Ji, Liang-Nian
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2010, 104 (05) : 576 - 582
  • [35] Influence of carboxylic acid functionalities in ruthenium (II) polypyridyl complexes on DNA binding, cytotoxicity and antioxidant activity: Synthesis, structure and in vitro anticancer activity
    Kamatchi, Thangavel Sathiya
    Chitrapriya, Nataraj
    Kim, Seog K.
    Fronczek, Frank R.
    Natarajan, Karuppannan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 59 : 253 - 264
  • [36] RAPID MINERALIZATION OF ORGANOPHOSPHONATES BY VISIBLE LIGHT-ENHANCED PEROXIDASE ACTION OF IRON(III) COMPLEXES
    INOUYE, Y
    JIROUSEK, M
    GRATZEL, CK
    GRATZEL, M
    JOURNAL OF MOLECULAR CATALYSIS, 1991, 68 (03): : L35 - L40
  • [37] Structure-activity relationships and DNA cleavage activity of bioreducible ruthenium(II) polypyridyl complexes
    Narh, Eugenia S.
    Singh, Shreeyukta
    MacDonnell, Frederick M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [38] Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents
    Liu, Jiangping
    Chen, Yu
    Li, Guanying
    Zhang, Pingyu
    Jin, Chengzhi
    Zeng, Leli
    Ji, Liangnian
    Chao, Hui
    BIOMATERIALS, 2015, 56 : 140 - 153
  • [39] Remarkable anticancer activity of ferrocenylterpyridine platinum(II) complexes in visible light with low dark toxicity
    Mitra, Koushambi
    Basu, Uttara
    Khan, Imran
    Maity, Basudev
    Kondaiah, Paturu
    Chakravarty, Akhil R.
    DALTON TRANSACTIONS, 2014, 43 (02) : 751 - 763
  • [40] Rhenium Complexes with Visible-Light-Induced Anticancer Activity
    Kastl, Anja
    Dieckmann, Sandra
    Waehler, Kathrin
    Voelker, Timo
    Kastl, Lena
    Merkel, Anna Lena
    Vultur, Adina
    Shannan, Batool
    Harms, Klaus
    Ocker, Matthias
    Parak, Wolfgang J.
    Herlyn, Meenhard
    Meggers, Eric
    CHEMMEDCHEM, 2013, 8 (06) : 924 - 927